Depatuxizumab MMAE
Based on 1 Customer Validation
Depatuxizumab MMAE is an antibody-drug conjugate (ADC) comprising an anti EGFR monoclonal antibody (Depatuxizumab) (HY-P99849) and the cytotoxic agent Monomethyl auristatin E (MMAE) (HY-15162). Depatuxizumab MMAE can be used for the study of EGFR-expressing advanced solid tumors.
For research use only. We do not sell to patients.
- Purity: 99.73%
- Molecular Weight:148000 (average)
-
Storage:
-80°C, protect from light
All EGFR Isoforms
More
Biological Activity
Chemical Information
-
Appearance Liquid
-
Molecular Weight 148000 (average)
-
Color Colorless to light yellow
-
SMILES
[Depatuxizumab MMAE]
-
Shipping
Shipping with dry ice.
-
Storage
-80°C, protect from light
Purity & Documentation
-
Data Sheet (238 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)